Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma.
about
Improving Decision Making about Genetic Testing in the Clinic: An Overview of Effective Knowledge Translation InterventionsNon-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issuesNon-Invasive Prenatal Testing Using Cell Free DNA in Maternal Plasma: Recent Developments and Future ProspectsIdentification of trisomy 18, trisomy 13, and Down syndrome from maternal plasmaSelected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditionsCell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service.Counseling Challenges with Variants of Uncertain Significance and Incidental Findings in Prenatal Genetic Screening and Diagnosis.Expanding diagnostic testing beyond cytogenetics: implications for birth defects research and surveillanceNon-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.Incorporation of dried blood alpha fetoprotein into traditional first trimester Down syndrome screening service.Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road?Uptake, outcomes, and costs of implementing non-invasive prenatal testing for Down's syndrome into NHS maternity care: prospective cohort study in eight diverse maternity units.Not-so-free testing for cell-free DNA.Non-invasive prenatal testing for aneuploidy: current status and future prospects.Role of the second-trimester 'genetic sonogram' for Down syndrome screen in the era of first-trimester screening and noninvasive prenatal testing.Clinical implementation of NIPT - technical and biological challenges.Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness researchChanging to NIPT as a first-tier screening test and future perspectives: opinions of health professionals.Women's Experiences of Publicly Funded Non-Invasive Prenatal Testing in Ontario, Canada: Considerations for Health Technology Policy-Making.Noninvasive prenatal testing by maternal plasma DNA analysis: current practice and future applications.Frequency of fetal karyotype abnormalities in women undergoing invasive testing in the absence of ultrasound and other high-risk indications.First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.A case of placental trisomy 18 mosaicism causing a false negative NIPT result.Maternal cfDNA screening for Down syndrome--a cost sensitivity analysis.First-trimester Down syndrome screening using additional serum markers with and without nuchal translucency and cell-free DNA.The clinical utility of DNA-based screening for fetal aneuploidy by primary obstetrical care providers in the general pregnancy population.QF-PCR rapid aneuploidy screen and aCGH analysis of cell free fetal (cff) DNA in supernatant of compromised amniotic fluids (AF).The price of performance: a cost and performance analysis of the implementation of cell-free fetal DNA testing for Down syndrome in Ontario, Canada.Noninvasive prenatal testing and fetal sonographic screening: roundtable discussion.Printing Unrealistic Expectations: A Closer Look at Newspaper Representations of Noninvasive Prenatal TestingWhat Is “NIPT”? Divergent Characterizations of Noninvasive Prenatal Testing Strategies
P2860
Q26764748-A0E69FC4-9E98-4FC0-9439-FD910A99E8D3Q26764809-B089D0D0-14E8-4B01-AE63-9346D0818A3AQ26827338-295E7BE4-3788-41D4-A3B2-9D02C35E5CCCQ27003962-E3A0654F-878E-4B14-AD95-38F3DCD11644Q30699635-4C49BC39-329B-4733-B596-6F9AD46FD1A1Q34426839-5F35180E-475D-4793-A66C-E189581E2932Q35142853-EAEEA604-A43E-4183-A5FE-F354D99A7ACAQ35667103-72D0A788-F96C-484A-A504-B51B356F06A8Q35900347-9A28E0C9-DE6C-4392-BB85-42D2B8604ABEQ36184534-C9A69188-0904-4DEB-A0B9-24CD9CE88535Q36402612-FEF97749-2574-4614-9B3B-8DF1B1E9A802Q36787475-AA5E7147-791B-44A5-A90F-EDA83D6F8407Q37067727-D94416FE-A00D-47ED-9D6C-6F86A8C01762Q37338477-D20D38A9-B8EC-4AC9-9F6E-962918BF4B5FQ38114375-429AABEE-13BE-42D2-8E1A-3BB16AC8F2ECQ38179321-EAE2F3CA-2E6A-4006-9731-7E9B186060BDQ38418240-92B25BE8-AFFC-4763-9234-DC0B54CF4985Q38730837-D8FEFD85-9295-492D-8705-FB050CD65E3EQ38959581-56C0DBF6-0076-406E-BEFB-DB3D5CDF00B5Q38996878-8507918F-6835-4632-B421-DA602625BB9EQ39149988-DB468FB5-2EEA-455A-B4EF-77FE577B4D00Q40524568-426ADF6A-BD9B-4C55-A468-E9921F757944Q41592901-4FD4D8AD-356F-4DB6-9151-A5311520DAC4Q43083929-863A675E-B014-4B4D-BB90-D43B61E3FB42Q43872436-3E4FD7D2-68DB-4701-84D4-D09A01E1AB2CQ44729421-808A74F8-7C68-452B-851B-438F5054EBB7Q46271940-75323056-AB7F-403C-91A4-A10EE291A82BQ46624086-716F4DBD-B362-471F-9111-B90858D2AF9AQ51125785-2913A8DA-997F-42D0-AA6E-EFC238ABFFAFQ52837725-D30D0FCE-6E4F-44CC-BAD9-25FCA5958F19Q58106679-E5E5B006-E08E-4AC3-B9A1-BDF7BA66549BQ58301130-5E79C9CC-9DA1-40A9-B5D4-6B0D617BBA90
P2860
Current status in non-invasive prenatal detection of Down syndrome, trisomy 18, and trisomy 13 using cell-free DNA in maternal plasma.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current status in non-invasive ...... l-free DNA in maternal plasma.
@en
type
label
Current status in non-invasive ...... l-free DNA in maternal plasma.
@en
prefLabel
Current status in non-invasive ...... l-free DNA in maternal plasma.
@en
P2093
P1476
Current status in non-invasive ...... l-free DNA in maternal plasma.
@en
P2093
GENETICS COMMITTEE
Jo-Ann Brock
Sylvie Langlois
P304
P356
10.1016/S1701-2163(15)31025-2
P577
2013-02-01T00:00:00Z